RTPM experiences: How it works well
Real-time prescription monitoring provides some, but not all information in supplying Controlled Drugs and other high-risk medicines. Here’s how it can help
What went right (and wrong) with Australia’s COVID-19 response?
COVID-19 enquiry criticises delays involving pharmacists in rollout, calling for urgent harmonisation of vaccine scope.
Supporting medicine management in patients with epilepsy
Managing medications for epilepsy presents unique challenges, demanding a careful balance of tailored care, patient education and ongoing support.
Vaccination tips for neurodiverse children this flu season
Busy pharmacies, bright lights and confined spaces can heighten fear surrounding vaccination, particularly for neurodiverse children.
Medicine safety announced as a National Health Priority Area
Medicine safety has been named a National Health Priority Area at PSA19 this morning, assuring greater focus for pharmacists’ roles in the quality and...
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2













